Advertisement

Topics

News Analysis: An End to Heart Disease? Not Quite

16:47 EDT 20 Mar 2017 | The New York Times News

The introduction of a new class of cholesterol drugs led some experts to believe that we might be able to virtually eliminate heart attacks. But it hasn’t worked out that way.

Original Article: News Analysis: An End to Heart Disease? Not Quite

NEXT ARTICLE

More From BioPortfolio on "News Analysis: An End to Heart Disease? Not Quite"

Quick Search
Advertisement
 

Relevant Topics

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...